Choice of replacement therapy for hemophilia-cryoprecipitate issues: a rebuttal.
Farrugia
A
A
Giangrande
P
P
D005169:Factor VIII / Q000592:standards / Q000627:therapeutic use*; D005340:Fibrinogen / Q000592:standards; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D038301:Virus Inactivation
C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen